Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 16.8 | 17.3 | 10.4 | 0.0 |
| Revenue growth | -2.9% | 66.1% | 41448.0% | |
| Cost of goods sold | 17.7 | 8.5 | 5.0 | 0.0 |
| Gross profit | -0.9 | 8.8 | 5.4 | 0.0 |
| Gross margin | -5.5% | 50.8% | 52.1% | 100.0% |
| Sales and marketing | 29.9 | 37.8 | 13.5 | 0.0 |
| Research and development | 23.5 | 21.0 | 11.2 | |
| General and administrative | 42.7 | 26.3 | 8.0 | 0.1 |
| EBIT | -97.0 | -76.5 | -27.3 | -0.1 |
| EBIT margin | -578.6% | -443.4% | -262.6% | -372.0% |
| Pre-tax income | -106.0 | -81.6 | -23.3 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -106.0 | -92.0 | -23.3 | 0.0 |
| Net margin | -632.4% | -533.2% | -224.0% | 0.0% |
| |
| Diluted EPS | ($2.70) | ($8.99) | ($11.13) | |
| Shares outstanding (diluted) | 39.3 | 10.2 | 2.1 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|